NORTHCOTT DEVON MEDICAL FOUNDATION
ANNUAL REPORT AND ACCOUNTS
YEAR TO 5TH APRIL 2021
Registered Charity Number 204660
NORTHCOTT DEVON MEDICAL FOUNDATION
YEAR TO 5TH APRIL 2021
| Trustees | : | Mr J F Thompson (Deceased 25 February 2021) |
|---|---|---|
| Dr M S Morgan (Chair) | ||
| Dr R Haigh | ||
| Secretary | : | Mr R E T Borton |
| Registered address | : | Stratus House |
| Emperor Way | ||
| Exeter Business Park | ||
| Exeter | ||
| EX1 3QS | ||
| Independent Examiner | : | Mr S Cann |
| Bush & Co | ||
| 2 Barnfield Crescent | ||
| Exeter | ||
| EX1 1QT | ||
| Bankers | : | Barclays Bank Plc |
| 20 High Street | ||
| Exeter | ||
| EX4 3LL | ||
| Investment Advisors | : | Brewin Dolphin |
| Vantage Point | ||
| Woodwater Park | ||
| Pynes Hill | ||
| Exeter | ||
| EX2 5FD | ||
| Solicitors | : | Foot Anstey |
| Senate Court | ||
| Southernhay Gardens | ||
| Exeter | ||
| EX1 1NT |
1
NORTHCOTT DEVON MEDICAL FOUNDATION
Registered Charity Number 204660
TRUSTEES' REPORT
The Trustees present their report and the accounts of the Foundation for the year ended 5 April 2021.
GOVERNING DOCUMENT
The Foundation was founded on 8 November 1961 and is constituted under a deed of trust by the late George Vernon Northcott, CBE. The charity’s registered office is given on page 1.
TRUSTEES AND PRINCIPAL ADVISERS
The names of the trustees and principal advisers are set out on page 1.
TRUSTEES' RESPONSIBILITIES
The trustees are responsible for the preparation of financial statements which give a true and fair view of the state of affairs of the Foundation at the end of each financial year and also of the financial activities for the year. In preparing these financial statements, the Trustees ensure that applicable accounting standards have been followed and that appropriate accounting policies supported where necessary by appropriate judgement and estimates, have been consistently applied.
The Trustees have also complied with the deed of trust by ensuring that administrative expenditure has been funded from income.
PRINCIPAL OBJECTS AND PUBLIC BENEFIT
The principal objects are to promote the improvement of medical practice, by supporting postgraduate medical education and medical research in the County of Devon.
In setting objectives and planning for activities, the Trustees have given due consideration to general guidance published by the Charity Commission relating to public benefit. The Trustees’ grant making policy is established in such a way that the Foundation achieves its objects for the public benefit, by seeking to improve medical practice.
ADMINISTRATIVE STRUCTURE
The Trustees are empowered by the deed of trust to appoint additional trustees and also to appoint persons to serve on an advisory committee which meets twice a year to consider grant applications.
The trustees and members of the advisory committee offer their services free of charge and are not remunerated for the expenses they incur. There are no other voluntary helpers.
The Secretary, Mr R E T Borton, is a partner in Bishop Fleming LLP, Chartered Accountants. That firm received £5,870 (2020: £5,770) exclusive of VAT by way of fees for secretarial and accounting services.
2
NORTHCOTT DEVON MEDICAL FOUNDATION
Registered Charity Number 204660
TRUSTEES' REPORT (Cont'd.)
REVIEW OF THE YEAR
As explained below, the Foundation's investment advisors are instructed to maximise total returns. During the year presented here, investment income decreased from £50,833 to £41,718. This is largely in line with the markets.
However, this has been more than offset by significant gains on the Foundation’s investments. After the losses of around £198,000 in 2019/20, again in line with markets at the start of the Coronavirus pandemic, the Foundation’s investment portfolio has increased significantly, from £1.594m at 5 April 2020 to £2.129m this year. The trustees are satisfied with the investment performance.
The Foundation receives a steady stream of worthy applications and the Trustees continue to balance the needs of current researchers with their objective to protect the time value of the charity’s funds for the future.
The grants awarded during the year were:-
£ Dr R Bescos 7,800 (University of Plymouth) The effect of bee propolis mouthwash on the composition and abundance of oral bacteria compared to chlorhexidine mouthwash in healthy humans Drs Coelho and Whatmore 6,720 (University of Exeter Medical School) An investigation into the role of the endothelial glycocalyx in the invasion of the brain by cryptococcus neoformans. Mr N Thomas 9,997 (University of Exeter Medical School) Can continuous glucose measures be used to predict insulin secretion in adult-onset diabetes? Mr J A Conway 5,982 (University of Plymouth) The influence of Nedd4 ligases on the dopaminergic midbrain and alpha synuclein in Parkinson’s Disease and Dementia with Lewy Bodies £ 30,499
Due to the coronavirus pandemic, a number of the studies that the Foundation is funding have had delayed starts or have had to be temporarily suspended. Accordingly, there have been fewer claims against grant awards than would have been expected during the year. Grants outstanding at the 5 April 2021 were £95,452.
3
NORTHCOTT DEVON MEDICAL FOUNDATION
Registered Charity Number 204660
TRUSTEES' REPORT (Cont'd.)
FINANCIAL POLICY (INVESTMENTS, RESERVES AND RISKS)
Whilst the Trustees have wide powers to make investments as they see fit, they maintain a medium risk balanced portfolio.
As the Trustees have the power to apply the capital of the fund to any of the charitable objects of the Foundation, since 2004, the Trustees have asked their investment adviser to try to maximise total return, without being concerned with the split between income and capital.
In the year reported here, having charged investment management costs to capital funds, there has been a small surplus on unrestricted income funds of £1.975 (2020 deficit £256), increasing the unspent income funds carried forward to £3,640.
Restricted funds of £365 remain for multiple sclerosis research and this amount will be used towards future grants for this purpose.
Overall, the Trustees’ aim is to maintain the value of capital in real terms and to apply income earned therefrom to award grants and to otherwise fulfil the charity’s objectives.
FUTURE COMMITMENTS
There were no commitments at the year-end that were not already recognised as liabilities in the accounts.
INDEPENDENT EXAMINER
A resolution proposing the re-appointment of Mr S Cann of Bush & Co will be put to a meeting of the Trustees.
SIGNED ON BEHALF OF THE TRUSTEES
R E T Borton Dr M S Morgan Secretary Trustee
4 February 2022
4
INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF
NORTHCOTT DEVON MEDICAL FOUNDATION
I report to the charity trustees on my examination of the accounts of the charity for the year ended 5 April 2021 which are set out on pages 6 to 11.
Responsibilities and basis of report
As the charity’s trustees you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 (‘the Act’).
I report in respect of my examination of the charity’s accounts carried out under section 145 of the Act and in carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.
Independent examiner's statement
I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
-
accounting records were not kept in respect of the charity as required by section 130 of the Act; or 2. the accounts do not accord with those records; or
-
the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a ‘true and fair view’ which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
S Cann FCCA ACA CTA Bush & Co Chartered Accountants 2 Barnfield Crescent Exeter EX1 1QT
4 February 2022
5
NORTHCOTT DEVON MEDICAL FOUNDATION
STATEMENT OF FINANCIAL ACTIVITIES
YEAR ENDED 5TH APRIL 2021
| Notes INCOME Income from UK quoted investments 2 Interest on cash deposits Donations Total income EXPENDITURE Raising funds Investment management charges Charitable activities Grants and lectures 3 Administrative expenses 4 Total expenditure Net income/(expenditure) before gains and losses Net gains/(losses) on investments NET INCOME/(EXPENDITURE) BALANCE BROUGHT FORWARD 6 April 2020 BALANCE CARRIED FORWARD 5 April 2021 9 |
Unrestricted £ 41,560 158 0 41,718 13,427 31,499 8,244 53,170 (11,452) 528,397 516,945 1,509,280 2,026,225 |
Restricted £ 0 0 0 0 365 365 |
2021 Total £ 41,560 158 0 41,718 13,427 31,499 8,244 53,170 (11,452) 528,397 516,945 1,509,645 ** 2,026,590** |
2020 £ 50,833 219 1,565 |
|---|---|---|---|---|
| 52,617 | ||||
| 13,260 34,148 8,100 |
||||
| 55,508 | ||||
| (2,891) (204,301) |
||||
| (207,192) 1,716,837 |
||||
| 1,509,645 | ||||
In 2020 £1,565 of income, £4,200 of expenditure and reserves carried forward of £365 related to restricted funds. The balance was unrestricted.
All activities were continuing activities.
6
NORTHCOTT DEVON MEDICAL FOUNDATION
BALANCE SHEET
5[TH] APRIL 2021
| Notes FIXED ASSETS UK Quoted investments 7 CURRENT ASSETS Brewin Dolphin Deposit Cash at Bank Debtors – accrued interest Creditors: Amounts falling due within 8 one year NET CURRENT ASSETS/(LIABILITIES) NET ASSETS Represented by:- UNRESTRICTED FUNDS 9 RESTRICTED FUNDS 9 |
2021 £ £ 2,069,446 59,993 59 486 60,538 (103,394) (42,856) 2,026,590 2,026,225 365 2,026,590 |
2020 £ £ 1,478,490 115,463 388 581 116,432 (85,277) 31,155 1,509,645 1,509,280 365 1,509,645 |
2020 £ £ 1,478,490 115,463 388 581 116,432 (85,277) 31,155 1,509,645 1,509,280 365 1,509,645 |
|---|---|---|---|
| 1,509,645 | |||
| 1,509,280 365 |
|||
| 1,509,645 |
The Accounts were approved by the Board of Trustees on 4 February 2022 and signed on its behalf by:-
Dr M S Morgan
7
NORTHCOTT DEVON MEDICAL FOUNDATION
NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 5TH APRIL 2021
1. ACCOUNTING POLICIES
The following accounting policies have been used consistently in dealing with items which are considered material in relation to the Foundation's Accounts.
-
(a) Basis of Preparation of Financial Statements
-
The financial statements have been prepared under the historical cost convention, as modified by the recognition of investment assets at fair value, and in accordance with the Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) effective 1 January 2019. The address of the registered office, the nature of the charity's operations and its principal activities are set out in the Trustees' report.
The financial statements have been prepared to give a "true and fair" view and have departed from the Charities (Accounts and Reports) Regulations 2008 only to the extent required to provide a "true and fair view". This departure has involved following the Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) effective 1 January 2019 rather than the Accounting and Reporting by Charities: Statement of Recommended Practice effective from 1 April 2005 which has been withdrawn.
The charity constitutes a public benefit entity as defined by FRS 102.
-
(b) Income from investments Dividends are accounted for when due and payable. Interest entitlements are accounted for as they accrue.
-
(c) Fixed Asset Investments
-
Fixed Asset Investments have been included in the balance sheet at 5 April 2021 fair value.
-
(d) Gains and Losses on investments Realised gains and losses are recognised when investments are sold. Unrealised gains and losses are accounted for on revaluation of investments at 5 April. All gains and losses, realised and unrealised, are accounted for through the Statement of Financial Activities.
-
(e) Grants payable
Grants are accounted for when awarded.
-
(f) Other expenditure
-
Other expenditure is accounted for on an accruals basis, including VAT which the Foundation cannot recover.
8
NORTHCOTT DEVON MEDICAL FOUNDATION
NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 5TH APRIL 2021 (Cont'd.)
- (g) Financial instruments The charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value.
(h) Preparation of the accounts on a going concern basis
- The trustees consider that there are no material uncertainties about the charity’s ability to continue as a going concern.
2. INCOME FROM UK QUOTED INVESTMENTS
| 2. INCOME FROM UK QUOTED INVESTMENTS Dividends and interest received 3. GRANTS AND LECTURES Grants awarded Grants released Grant claim against previously released awards |
2021 £ 41,560 2021 £ 30,499 1,000 31,499 |
2020 £ 50,833 |
|---|---|---|
| 2020 £ 36,289 (2,141) |
||
| 34,148 |
Details of the recipients and purpose of grants are given in the Trustee's Report, under Review of the Year on page 3. All grants were awarded from unrestricted funds and none were awarded from restricted funds, (2020 £4,200 from restricted, with the balance from unrestricted).
| 4. ADMINISTRATIVE EXPENSES Secretarial and Accountancy Independent Examination Trustee Indemnity Insurance Meeting expenses |
2021 £ 7,044 768 408 24 8,244 |
2020 £ 6,924 750 408 18 |
|---|---|---|
| 8,100 |
5. TRUSTEES’ REMUNERATION AND EXPENSES
The Trustees act in a voluntary capacity. They receive no remuneration and are paid no expenses.
6. RELATED PARTY TRANSACTIONS
The Secretary, Mr R E T Borton, is a partner in Bishop Fleming LLP, Chartered Accountants. That firm received £5,870 (2020: £5,770) exclusive of VAT by way of fees for secretarial and accounting services.
9
NORTHCOTT DEVON MEDICAL FOUNDATION
NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 5TH APRIL 2021 (Cont'd.)
| 7. UK QUOTED INVESTMENTS Balance brought forward at valuation Acquisitions at cost Disposals at valuation Revaluation at 5 April 2021 Balance carried forward at valuation Quoted investments stated at historic cost The following investments represent more than 5% of J P Morgan American Investment Trust Vanguard Funds S&P 500 8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR Accrued expenses Grants outstanding 9. RESTRICTED FUNDS |
2021 2020 £ £ 1,478,490 1,714,029 339,103 340,255 (234,950) (365,931) 1,582,643 1,688,353 486,803 (209,863) 2,069,446 1,478,490 1,365,878 1,242,836 the investment portfolio: 4.0% 7.7% 6.6% 6.5% 2021 2020 £ £ 7,942 7,973 95,452 77,304 |
2020 £ 1,714,029 340,255 (365,931) |
|---|---|---|
| 1,688,353 (209,863) |
||
| 1,478,490 | ||
| 1,242,836 | ||
| 103,394 85,277 |
||
During the previous year donations of £1,565 were received towards Multiple Sclerosis research. A grant was awarded during that year for £4,200, leaving £365 carried forward at the 5 April 2020 and 2021. All other funds stated below represent unrestricted funds.
| UNRESTRICTED FUNDS At cost Revaluation surplus Being:- Capital Income |
2021 £ 1,322,657 703,568 2,026,225 2,022,585 3,640 2,026,225 |
2020 £ 1,273,626 235,654 |
|---|---|---|
| 1,509,280 | ||
| 1,507,615 1,665 |
||
| 1,509,280 |
10
NORTHCOTT DEVON MEDICAL FOUNDATION
NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 5TH APRIL 2021 (Cont'd.)
| 10. FINANCIAL INSTRUMENTS Financial assets measured at fair value through income and expenditure Investments Financial assets measured at amortised cost Accrued income Cash at bank Financial liabilities measured at amortised cost Accrued expenses Grants outstanding |
2021 £ 2,069,446 486 60,052 2,129,984 (7,942) (95,452) **(103,394) ** |
2020 £ 1,478,490 581 115,851 |
|---|---|---|
| 1,594,922 | ||
| (7,973) (77,304) |
||
| (85,277) |
11